SCHEMBL10025832

SCHEMBL10025832

c1ccc2c(c1)c1ccc(c3ccccc3c3c4ccccc4c(c4ccccc43)c3ccccc3c3c4ccccc4c2c2ccccc23)c2nccnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.44
HSP90AA1 P07900 2/20 0.44
NPC1 O15118 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CCR1 P32246 6/20 0.41
CCR8 P51685 6/20 0.41
CCR5 P51681 4/20 0.41
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 1/20 0.39
THRB P10828 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
PARP1 P09874 3/20 0.38
TYMS P04818 1/20 0.37
LMNA P02545 4/20 0.36
MAPT P10636 3/20 0.36
CYP3A4 P08684 2/20 0.36
PMP22 Q01453 2/20 0.36
APEX1 P27695 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30863911 0.89 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL713323 0.89 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL21298469 0.88 L3MBTL1 (0.43) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL15251334 0.87 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL29489795 0.87 L3MBTL1 (0.50) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL21791178 0.85 HPRT1 (0.44) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL18816320 0.84 L3MBTL1 (0.52) L3MBTL1HSP90AA1NPC1MEN1KMT2A
SCHEMBL31607191 0.83 HPRT1 (0.48) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL21297912 0.83 HPRT1 (0.48) L3MBTL1HSP90AA1NPC1CCR1CCR8
SCHEMBL21298467 0.82 HSP90AA1 (0.41) L3MBTL1HSP90AA1NPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-8124249-B2 Derivatives of fused aromatic systems; stability; sublimation stability; easy to purify due to better solubilty; easy reproducibility because do not form isomers MERCK PATENT GMBH (DE) 2012-02-28 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171225-A1 Novel Materials For Organic Electroluminescent Devices OR10J3, EML4, TYR L3MBTL1 1759/4885HSP90AA1 4475/4885NPC1 4266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.